Clinical Trial Update: Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing daptomycin to vancomycin or teicoplanin for complicated skin and skin-structure infections; the study was terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• Daptomycin (Cubicin) (daptomycin)
• Teicoplanin (Teicoplanin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Skin Diseases, Infectious, Soft Tissue Infections | Phase 3 | Status: TERMINATED | Results posted: 2011-01-05